Sympathomimetic medications: Nursing pharmacology

1,163views

Sympathomimetic medications: Nursing pharmacology

Medical Surgical

Medical Surgical

Arrhythmias - Asystole: Nursing
Arrhythmias - Atrial fibrillation (Afib): Nursing
Arrhythmias - Atrial flutter (Aflutter): Nursing
Arrhythmias - Heart blocks: Nursing
Arrhythmias - Premature atrial contractions (PACs): Nursing
Arrhythmias - Premature ventricular contractions (PVCs): Nursing
Arrhythmias - Sinus tachycardia and sinus bradycardia: Nursing
Arrhythmias - Supraventricular tachycardia (SVT): Nursing
Arrhythmias - Ventricular fibrillation (Vfib): Nursing
Arrhythmias - Ventricular tachycardia (Vtach): Nursing
Arterial embolism: Nursing
Electrocardiogram (ECG) - Normal sinus rhythm (NSR): Nursing
Cardiomyopathy: Nursing
Congenital heart defects - Acyanotic: Nursing
Congenital heart defects - Cyanotic: Nursing
Endocarditis: Nursing
Heart defects that decrease pulmonary blood flow - Nursing considerations & client education: Nursing
Kawasaki disease: Nursing
Myocarditis: Nursing
Pericarditis: Nursing
Shock - Anaphylactic: Nursing
Shock - Cardiogenic: Nursing
Shock - Hypovolemic: Nursing
Shock - Neurogenic: Nursing
Shock - Obstructive: Nursing
Shock - Septic: Nursing
Valvular heart disease: Nursing
Geriatric considerations - Cardiac: Nursing
Aortic aneurysm: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Left-sided heart failure: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Pericardial effusion and cardiac tamponade: Nursing process (ADPIE)
Rheumatic heart disease: Nursing process (ADPIE)
Alpha-1 adrenergic blockers: Nursing pharmacology
Alpha-2 adrenergic agonists: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Nitrates: Nursing pharmacology
Sympathomimetic medications: Nursing pharmacology
Adrenal insufficiency (Addison disease): Nursing
Cushing syndrome and Cushing disease: Nursing
Hyperparathyroidism: Nursing
Hypoparathyroidism: Nursing
Hypopituitarism: Nursing
Infant of a diabetic mother (IDM): Nursing
Phenylketonuria (PKU): Nursing
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Insulin: Nursing pharmacology
Medications affecting the parathyroid glands: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Amblyopia: Nursing
Cataracts: Nursing
Detached retina: Nursing
Hearing impairment and otosclerosis: Nursing
Legal blindness: Nursing
Macular degeneration: Nursing
Meniere disease: Nursing
Pharyngitis: Nursing
Strabismus: Nursing
Geriatric considerations - Sensory: Nursing
Otitis media: Nursing
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Biliary atresia: Nursing
Cholecystitis: Nursing
Cholelithiasis: Nursing
Diarrhea: Nursing
Diverticular disease: Nursing
Hepatitis: Nursing
Inflammatory bowel disease - Crohn disease and ulcerative colitis: Nursing
Intestinal obstruction: Nursing
Irritable bowel syndrome (IBS): Nursing
Jaundice: Nursing
Esophageal atresia and tracheoesophageal fistula: Nursing
Geriatric considerations - Gastrointestinal: Nursing
Hirschsprung disease: Nursing
Hyperemesis gravidarum: Nursing
Necrotizing enterocolitis: Nursing
Omphalocele and gastroschisis: Nursing
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antiemetics: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Laxatives: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Chronic kidney disease (CKD): Nursing
Dialysis care: Nursing
Epididymitis: Nursing
Glomerulonephritis: Nursing
Nephrotic syndrome: Nursing
Polycystic kidney disease (PKD): Nursing
Pyelonephritis: Nursing
Renal and urinary calculi: Nursing
Urinary retention: Nursing
Bladder exstrophy: Nursing
Circumcision: Nursing
Cryptorchidism: Nursing
Enuresis: Nursing
Geriatric considerations - Urinary: Nursing
Hypospadias and epispadias: Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Urinary tract infections (UTIs): Nursing process (ADPIE)
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Anemia - Aplastic: Nursing
Anemia - Iron-deficiency: Nursing
Anemia - Macrocytic: Nursing
Disseminated intravascular coagulation (DIC): Nursing
Neutropenia: Nursing
Polycythemia: Nursing
Thalassemia: Nursing
Thrombocytopenia: Nursing
Arterial blood gas (ABG) - Overview: Nursing
Arterial blood gas (ABG) - Metabolic acidosis: Nursing
Arterial blood gas (ABG) - Respiratory alkalosis: Nursing
Blood cultures: Nursing
Cardiac biomarkers - Creatine kinase (CK): Nursing
Cardiac biomarkers - Troponin: Nursing
Coagulation studies - Partial thromboplastin time (PTT): Nursing
Complete blood count (CBC) - Hemoglobin and hematocrit: Nursing
Complete blood count (CBC) - Platelets: Nursing
Complete blood count (CBC) - Red blood cells (RBC): Nursing
Complete blood count (CBC) - White blood cells (WBC) and differential: Nursing
Complete metabolic panel (CMP) - Blood urea nitrogen (BUN) and creatinine (Cr): Nursing
Complete metabolic panel (CMP) - Chloride: Nursing
Complete metabolic panel (CMP) - Estimated glomerular filtration rate (eGFR): Nursing
Complete metabolic panel (CMP) - Glucose: Nursing
Complete metabolic panel (CMP) - Liver function tests (LFT): Nursing
Complete metabolic panel (CMP) - Potassium: Nursing
Complete metabolic panel (CMP) - Sodium: Nursing
Hemolytic disease of the fetus and newborn: Nursing
Hemolytic uremic syndrome: Nursing
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Blood products: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Immune response - Adaptive: Nursing
Autoimmunity: Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type II: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Inflammatory process: Nursing
Immune response - Innate: Nursing
Immunodeficiency disorders - Primary: Nursing
Scleroderma: Nursing
Immunodeficiency disorders - Secondary: Nursing
Sjögren syndrome: Nursing
Systemic lupus erythematosus (SLE): Nursing
Toxic shock syndrome (TSS): Nursing
Erythema infectiosum (Fifth disease): Nursing
Fever: Nursing
Infectious mononucleosis: Nursing
Mumps (Parotitis): Nursing
Neonatal sepsis: Nursing
Pertussis: Nursing
Poliomyelitis: Nursing
Postpartum infections: Nursing
Roseola (Exanthem subitum): Nursing
Rubella (German measles): Nursing
Rubeola (Measles): Nursing
Smallpox: Nursing
Zika virus: Nursing
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Antirejection immunosuppressants: Nursing pharmacology
Biologic agents: Nursing pharmacology
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Acne: Nursing
Animal and snake bites: Nursing
Burn injury: Nursing
Cutaneous fungal infections: Nursing
Erysipelas and cellulitis: Nursing
Herpes simplex virus (HSV): Nursing
Herpes zoster: Nursing
Impetigo: Nursing
Insect stings and bites: Nursing
Pediculosis and scabies: Nursing
Psoriasis: Nursing
Rocky Mountain spotted fever (RMSF): Nursing
Skin cancer - Basal cell carcinoma, squamous cell carcinoma, and melanoma: Nursing
Urticaria: Nursing
Geriatric considerations - Integumentary: Nursing
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Amputation: Nursing
Carpal tunnel syndrome: Nursing
Herniated intervertebral disc: Nursing
Hip fractures: Nursing
Muscular dystrophies - Duchenne and Becker: Nursing
Myasthenia gravis: Nursing
Osteoarthritis: Nursing
Osteomyelitis: Nursing
Osteoporosis: Nursing
Paget disease of bone: Nursing
Craniosynostosis: Nursing
Developmental dysplasia of the hip: Nursing
Juvenile idiopathic arthritis: Nursing
Scoliosis: Nursing
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Altered level of consciousness (LOC): Nursing
Amyotrophic lateral sclerosis (ALS): Nursing
Bell palsy: Nursing
Cerebral palsy: Nursing
Encephalitis: Nursing
Guillain-Barré syndrome: Nursing
Head injury: Nursing
Hemorrhagic stroke - Intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH): Nursing
Epidural and subdural hematoma: Nursing
Huntington disease: Nursing
Increased intracranial pressure (ICP): Nursing
Intracranial aneurysm: Nursing
Migraines: Nursing
Multiple sclerosis (MS): Nursing
Physiology of pain: Nursing
Spinal cord injury (SCI): Nursing
Delirium: Nursing
Dementia: Nursing
Brachial plexus injury: Nursing
Neurological assessment - Neonate: Nursing
Neural tube defects: Nursing
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Biology of cancer: Nursing
Bladder tumors: Nursing
Bone tumors: Nursing
Brain tumors: Nursing
Cervical cancer: Nursing
Colorectal cancer: Nursing
Esophageal cancer: Nursing
Gastric cancer: Nursing
Laryngeal cancer: Nursing
Liver cancer: Nursing
Lung cancer: Nursing
Lymphoma - Hodgkin and non-Hodgkin: Nursing
Multiple myeloma: Nursing
Neuroblastoma: Nursing
Ovarian cancer: Nursing
Pancreatic cancer: Nursing
Prostate cancer: Nursing
Renal cancer: Nursing
Retinoblastoma: Nursing
Testicular cancer: Nursing
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Alkylating agents: Nursing pharmacology
Angiogenesis inhibitors: Nursing pharmacology
Antimetabolites: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Hormones and hormone modulators for cancer: Nursing pharmacology
Other antineoplastics: Nursing pharmacology
Plant extracts for chemotherapy: Nursing pharmacology
Platinum-based agents: Nursing pharmacology
Buerger disease: Nursing
Raynaud phenomenon: Nursing
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Contraception - Barrier methods: Nursing
Contraception - Hormonal methods: Nursing
Contraception - Natural methods: Nursing
Contraception - Permanent methods: Nursing
Endometriosis: Nursing
Genital warts: Nursing
Infertility: Nursing
Syphilis: Nursing
Gestational trophoblastic disease: Nursing
Precocious puberty: Nursing
Candidiasis: Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Acute respiratory distress syndrome (ARDS): Nursing
Anthrax: Nursing
Aspergillosis: Nursing
Atelectasis: Nursing
Chest tube care: Nursing
COVID-19: Nursing
Cystic fibrosis: Nursing
Flail chest: Nursing
Influenza: Nursing
Pleural effusion: Nursing
Pleurisy: Nursing
Pneumothorax and hemothorax: Nursing
Pulmonary contusion: Nursing
Pulmonary edema: Nursing
Rib fracture: Nursing
Rupture of diaphragm: Nursing
Sarcoidosis: Nursing
Tuberculosis (TB): Nursing
Bronchopulmonary dysplasia (BPD): Nursing
Congenital diaphragmatic hernia: Nursing
Geriatric considerations - Respiratory: Nursing
Neonatal respiratory distress syndrome (NRDS): Nursing
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Bronchiolitis and respiratory syncytial virus (RSV): Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Preoperative care: Nursing
Postoperative care: Nursing
Palliative and hospice care: Nursing
Postmortem care and considerations: Nursing

Notes





SYMPATHOMIMETIC MEDICATIONS, PART 1/2
DRUG NAME
dobutamine
dopamine
CLASS
Sympathomimetics
β1-agonist
β1- and α-agonist
MECHANISM of ACTION
Stimulates β1-adrenergic receptors → increases contractility and cardiac output
Stimulates β1-adrenergic receptors → increases contractility and cardiac output

Stimulates β1- and α-receptors → vasoconstriction → increases blood pressure
INDICATIONS
  • Cardiac decompensation
  • Unlabeled: cardiogenic shock in children
  • Shock
  • Hypotension
  • Unlabeled: bradycardia
  • Cardiac arrest
ROUTE(S) of ADMINISTRATION
  • IV
  • IV
SIDE EFFECTS
  • CV: palpitations, tachycardia, hypertension, angina, arrhythmias
  • GI: nausea, vomiting
  • CNS: cerebral hemorrhage
  • Dopamine, epinephrine, norepinephrine: extravasation (boxed warning), tissue necrosis, sloughing, gangrene
  • Epinephrine: hyperglycemia (clients with diabetes)
CONTRAINDICATIONS & CAUTIONS
  • Pregnancy and breastfeeding
  • Elderly clients
  • Hypertension or coronary artery disease
  • Dobutamine
    • hypertrophic cardiomyopathy with outflow tract obstruction
  • Norepinephrine:
    • hypovolemia, mesenteric or peripheral thrombosis
  • Dopamine: 
    • tachyarrhythmias, ventricular fibrillation, pheochromocytoma, hypovolemia
  • Isoproterenol: 
    • tachyarrhythmias, angina pectoris, cardiac glycoside toxicity
  • Epinephrine:
    • closed-angle glaucoma, non-anaphylactic shock

Drug interactions:
  • Dobutamine: COMT inhibitors
  • Dopamine, epinephrine, norepinephrine: MAO inhibitors, TCAs
  • Combining sympathomimetic medications


SYMPATHOMIMETIC MEDICATIONS, PART 2/2
DRUG NAME
epinephrine (Adrenalin,
Adrenaclick, Epipen)

norepinephrine (Levophed)
isoproterenol (Isuprel)
CLASS
Sympathomimetics
Bronchodilator Nonselective adrenergic agonist
Nonselective
adrenergic agonist
Nonselective beta-adrenergic agonist
MECHANISM of ACTION
Stimulates β1- and β2-agonist →
bronchodilation, cardiac and CNS stimulation
Stimulates β-receptors in heart → increases contractility, heart rate, and cardiac output

Stimulates β1- and α-receptors → vasoconstriction → increases blood pressure

Stimulates β1- and β2-agonist →
bronchodilation, cardiac and CNS stimulation
INDICATIONS
  • Acute asthmatic attacks
  • Bronchospasm
  • Anaphylaxis, allergic reactions
  • Cardiac arrest
  • Shock
  • Acute hypotension
  • Shock
  • Episodes of heart block
  • Cardiac arrest, CPR
  • Bronchospasm occurring during anesthesia
  • Shock, congestive heart failure
ROUTE(S) of ADMINISTRATION
  • IV
  • IM
  • INH
  • ET tube
  • IV
  • IV
  • IM
SIDE EFFECTS
  • CV: palpitations, tachycardia, hypertension, angina, arrhythmias
  • GI: nausea, vomiting
  • CNS: cerebral hemorrhage
  • Dopamine, epinephrine, norepinephrine: extravasation (boxed warning), tissue necrosis, sloughing, gangrene
  • Epinephrine: hyperglycemia (clients with diabetes)
CONTRA-INDICATIONS & CAUTIONS
  • Pregnancy and breastfeeding
  • Elderly clients
  • Hypertension or coronary artery disease
  • Dobutamine
    • hypertrophic cardiomyopathy with outflow tract obstruction
  • Norepinephrine:
    • hypovolemia, mesenteric or peripheral thrombosis
  • Dopamine: 
    • tachyarrhythmias, ventricular fibrillation, pheochromocytoma, hypovolemia
  • Isoproterenol: 
    • tachyarrhythmias, angina pectoris, cardiac glycoside toxicity
  • Epinephrine:
    • closed-angle glaucoma, non-anaphylactic shock

Drug interactions:
  • Dobutamine: COMT inhibitors
  • Dopamine, epinephrine, norepinephrine: MAO inhibitors, TCAs
  • Combining sympathomimetic medications
NURSING CONSIDERATIONS for
SYMPATHOMIMETIC MEDICATIONS
ASSESSMENT & MONITORING

Assessment and monitoring - norepinephrine

Assessment
  • Weight
  • Orientation, LOC
  • Hemodynamic status
  • Respiratory status 

Intervention and monitoring
  • Administer via central line
  • Low dose titrated based on client’s response

Monitoring
  • Hemodynamic status
  • Intake and output
  • LOC
  • Side effects
    • Paresthesias, cool extremities
    • Extravasation
      • Stop infusion
      • Notify health care provider
      • Administer phentolamine mesylate subcutaneously
  • Evaluate for the therapeutic response of blood pressure stabilization.
CLIENT EDUCATION
  • Purpose of medication: increase their blood pressure
  • Administered as a continuous infusion, adjusted as needed
Author: Victoria S. Recalde, MD
Author: Kelsey LaFayette, BAN, RN
Illustrator: Elijah Lee, MScBMC

Transcript

Watch video only

Sympathomimetics are medications that mimic the effect of endogenous catecholamines, like norepinephrine and epinephrine. As a result, these medications activate the sympathetic nervous system, which in turn triggers the fight or flight response, ultimately increasing the heart rate and blood pressure, as well as slowing down digestion. This response maximizes blood flow to the muscles and brain.

Now, sympathomimetic medications include dobutamine, dopamine, norepinephrine, epinephrine, and isoproterenol. All of them are administered intravenously, while isoproterenol can also be given intramuscularly, and epinephrine can also be administered intramuscularly, as well as through endotracheal tube or inhalation.

Once administered, sympathomimetic medications act by stimulating adrenergic receptors. Now, there are two main groups of adrenergic receptors: the alpha receptors, and beta receptors. Alpha adrenergic receptors are mainly located on the walls of blood vessels of the skin, as well as the gastrointestinal and genitourinary systems, and when stimulated, they cause vasoconstriction and decreased blood flow to these tissues.

On the other hand, beta receptors have two main subtypes: beta-1 and beta-2. Beta-1 adrenergic receptors are mainly located in the heart, and when activated, they increase the heart rate and contractility, which helps pump out more blood. On the other hand, beta-2 adrenergic receptors are found on smooth muscle cells in the walls of blood vessels supplying skeletal muscles and the brain, so their activation leads to vasodilation and increased blood flow to these tissues; and in the lungs, they cause bronchodilation.

Each type of adrenergic agonists stimulate these receptors to a different degree, which makes them useful to treat different conditions. But in general, all of them activate beta-1 receptors, so they all increase heart contractility, helping in the treatment of conditions where the cardiac output is decreased.

Now, all of these medications can be used to treat cardiac decompensation and shock. In addition, dopamine can also be used to treat bradycardia and post-cardiac arrest after shock. Norepinephrine is mainly used to treat acute hypotension and shock. Epinephrine is used to treat cardiac arrest, shock, and anaphylactic reactions; and because of its action on beta-2 adrenergic receptors, it’s also useful to treat acute asthmatic attacks and bronchospasm. Finally, isoproterenol is used in the treatment of cardiac arrest, episodes of heart block, congestive heart failure, shock, and bronchospasm that may occur during anesthesia.

Now, most side effects of these medications are the result of their action on adrenergic receptors. Clients on sympathomimetics may also experience gastrointestinal side effects, such as nausea and vomiting. Sympathomimetics can also be associated with cardiovascular side effects, including hypertension, and tachycardia, while more serious side effects of adrenergic agonists include angina and arrhythmias, while excessive hypertension can even result in cerebral hemorrhage.

Dopamine, epinephrine, and norepinephrine have a boxed warning for extravasation, which can lead to tissue necrosis, sloughing, and gangrene. Finally, epinephrine can cause hyperglycemia in clients with diabetes.

As far as contraindications go, all sympathomimetic medications should be used with caution during pregnancy and breastfeeding, as well as in elderly clients and those with hypertension or coronary artery disease. In addition, dobutamine is contraindicated in clients with hypertrophic cardiomyopathy with outflow tract obstruction.

On the other hand, norepinephrine should be used with caution when there’s hypovolemia or mesenteric or peripheral thrombosis, and clients on this medication should have adequate blood volume to avoid reduced blood flow, ischemia, and tissue hypoxia from the vasoconstriction.

Dopamine is also contraindicated in clients with tachyarrhythmias, ventricular fibrillation, pheochromocytoma, and hypovolemia. Next, isoproterenol is contraindicated in clients with tachyarrhythmias or angina pectoris, as well as in those experiencing cardiac glycoside toxicity. Finally, epinephrine shouldn’t be given to clients with closed-angle glaucoma and those having a non-anaphylactic shock.

Key Takeaways

Sympathomimetic medications are drugs that mimic the effects of the sympathetic nervous system. They work by mimicking the effect of endogenous catecholamines, like norepinephrine and epinephrine, and can be used to treat conditions such as cardiac decompensation, shock, anaphylaxis, bronchospasm, and bradycardia post-cardiac arrest. Some common examples of sympathomimetic medications include dobutamine, dopamine, norepinephrine, epinephrine, and isoproterenol.

Once administered, these medications stimulate two types of adrenergic receptors, alpha, and beta. With alpha-adrenergic receptor stimulation, vasoconstriction occurs, whereas stimulation of beta-1 adrenergic receptors causes increased heart rate and contractility, and stimulation of beta-2 adrenergic receptors causes vasodilation and bronchodilation.

Common side effects of sympathomimetics include gastrointestinal disturbances, hypertension, and arrhythmias. Nursing considerations for clients receiving sympathomimetics include monitoring their hemodynamic status; titrating doses as needed; monitoring for side effects; and assessing for the desired therapeutic response. Client education is focused on what to expect during treatment.

Sources

  1. "Karch’s Focus on Nursing Pharmacology. 9th edition. ISBN: 978-1-975180-40-9 " LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach. 9th edition. ISBN: 978-0-323-39916-6 " Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference. 36th edition. ISBN: 978-0-323-93072-7" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN. 9th Edition. ISBN: 978-0-323-79530-2" Saunders (2022)
  5. "Shock - Classification and Pathophysiological Principles of Therapeutics. 15(2):102-113" Curr Cardiol Rev (2019)
  6. "Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis. 22(2):196-203" West J Emerg Med (2021 Feb 16)
  7. "Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis. 148(5):1307-1315" J Allergy Clin Immunol (2021 )